Carteolol/latanoprostAlternative Names: Carteolol hydrochloride/latanoprost; Mikeluna; OPC-1085EL
Latest Information Update: 05 Oct 2016
At a glance
- Originator Otsuka Pharmaceutical
- Class Antiglaucomas; Antihypertensives; Propanolamines; Prostaglandins; Small molecules
- Mechanism of Action Beta-adrenergic receptor antagonists; Prostaglandin F2 alpha agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Registered Glaucoma; Ocular hypertension